- Report
- March 2025
- 187 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 184 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 187 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- August 2024
- 250 Pages
Global
From €2195EUR$2,290USD£1,834GBP
- Report
- March 2025
- 193 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 189 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- April 2025
- 183 Pages
Global
From €4745EUR$4,950USD£3,965GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- April 2025
- 282 Pages
Global
From €5225EUR$5,450USD£4,366GBP
- Report
- April 2025
- 441 Pages
Global
From €4745EUR$4,950USD£3,965GBP
- Report
- March 2025
- 175 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- September 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- July 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- January 2025
- 143 Pages
Global
From €2875EUR$2,999USD£2,402GBP
- Report
- August 2024
- 147 Pages
Global
From €2875EUR$2,999USD£2,402GBP
- Report
- January 2025
- 142 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Report
- October 2024
- 200 Pages
Global
From €4744EUR$4,949USD£3,964GBP
- Report
- December 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP

The Autoimmune Disorder market is a subset of the Allergy and Immunology field. It focuses on the diagnosis and treatment of diseases caused by an overactive immune system. These diseases can affect any organ or tissue in the body, and can range from mild to life-threatening. Common autoimmune disorders include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment typically involves medications to suppress the immune system, as well as lifestyle changes to reduce inflammation.
The Autoimmune Disorder market is highly competitive, with many companies offering treatments and therapies. These include pharmaceutical companies such as AbbVie, Amgen, and Biogen, as well as biotechnology companies such as Gilead Sciences and Celgene. Additionally, there are a number of smaller companies that specialize in specific autoimmune disorders, such as Mylan and Alexion Pharmaceuticals. Show Less Read more